UNSPSC 51452904: Uredofos

This classification denotes an antihelminthic agent with the molecular formula C19H25N4O6PS2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P8W25X9B3K, chemically known as rh-32,565 but generally known as uredofos, which bears US NIH Compound Identifier 3033943. European Medicines Agency schedules Uredofos in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11386MIG. The term UREDOFOS is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17).

UNSPSC 51452904 Uredofos, a Commodity code, does not align with recent state and local procurement activity in the available opportunity records. The four opportunities tagged under this code solicit naloxone and drug deactivation systems, direct-to-manufacturer pharmacy programs, medical and first aid supplies for emergency response, and generic pharmaceuticals and over-the-counter products — none of which represent uredofos, an organophosphate pesticide compound. The mismatch suggests either a cataloging error in the source data or that uredofos procurement does not currently appear in state and local public records tracked through standard solicitation channels.

The recent opportunities show activity across Florida (Seminole County), Texas (Health and Human Services Commission), Minnesota and Oregon (through MMCAP cooperative purchasing), and Florida again (City of Tampa), but none relate to the nominal scope of the uredofos code. Seminole County issued IFB 60459723LAS on June 30, 2026, for naloxone and drug deactivation systems with a July 26, 2023, response date; Texas HHS issued RFI HHS0017013 on April 3, 2026, for direct-to-manufacturer prescription program capabilities; the City of Tampa released IFB 26P00145 on March 25, 2026, for $700,000 in medical and first aid supplies for fire rescue with a March 13, 2026, deadline and a certified Small Local Business Enterprise set-aside; and MMCAP posted RFP S1070000015802 on January 20, 2026, for generic pharmaceuticals and OTC products with a March 26, 2026, response date. No current state or local purchasing activity under this code reflects uredofos procurement.